TY - JOUR
T1 - The Molecular Epidemiology and Clinical Phylogenetics of Rhinoviruses Among Paediatric Cases in Sydney, Australia
AU - Adam, Dillon Charles
AU - Chen, Xin
AU - Scotch, Matthew
AU - MacIntyre, Chandini Raina
AU - Dwyer, Dominic
AU - Kok, Jen
N1 - Funding Information:
We would like to acknowledge the support for DCA through an Australian Government Research Training Program Scholarship. We would also like to acknowledge support from the tri-university (Arizona State University, King's College London, and University of New South Wales) PLuS Alliance.
Funding Information:
We would like to acknowledge the support for DCA through an Australian Government Research Training Program Scholarship. We would also like to acknowledge support from the tri-university (Arizona State University, King's College London, and University of New South Wales) PLuS Alliance. This work was supported by a grant from the NHRMC Centre for Research Excellence in Integrated Systems for Epidemic Response (ISER) [grant number 1107393] to DCA, XC and CRM. DCA and CRM are also supported by an NHMRC Postgraduate Scholarship [grant number 1169037] and NHMRC Principal Research Fellowship [grant number 1137582], respectively. MS is also supported by the National Library of Medicine of the National Institutes of Health [grant number R01LM012080]. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The funders had no role in the study's conception, design, data collection and interpretation, or the decision to submit the work for publication. The human sequence data used in this study were publicly available from GenBank. This study was approved by the UNSW Human Research Ethics Committee (HC17284). CRM has received funding for investigator-driven research from Merck, GSK and Seqirus, and support for laboratory testing unrelated to this study from Pfizer. CRM has also been on advisory boards for the same companies. DCA, XC, MS, DD and JK have no competing interests to declare.
Funding Information:
This work was supported by a grant from the NHRMC Centre for Research Excellence in Integrated Systems for Epidemic Response (ISER) [grant number 1107393] to DCA, XC and CRM. DCA and CRM are also supported by an NHMRC Postgraduate Scholarship [grant number 1169037] and NHMRC Principal Research Fellowship [grant number 1137582], respectively. MS is also supported by the National Library of Medicine of the National Institutes of Health [grant number R01LM012080]. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The funders had no role in the study's conception, design, data collection and interpretation, or the decision to submit the work for publication.
Publisher Copyright:
© 2021 The Authors
PY - 2021/9
Y1 - 2021/9
N2 - Objectives: Rhinoviruses (RV) represent the most common aetiological agent of all acute respiratory tract infections across all age groups and a significant burden of disease among children. Recent studies have shown that RV-A and RV-C species are associated with increased disease severity. In order to better understand the potential associations between RV species and clinical features among paediatric cases, this study aimed to integrate genetic and epidemiological data using Bayesian phylogenetic methods. Methods: Potential associations between RV species and subtypes, and clinical disease severity using a matched dataset of 52 RV isolates sampled from children (< 18 years) in Sydney, Australia, between 2006 and 2009 were uncovered using epidemiological and phylogenetic methods. Results: It was found that RV-C was significantly more likely to be isolated from paediatric cases aged < 2 years compared with RV-A, although no significant differences in recorded symptoms were observed. Significant phylogenetic-trait associations between age and the VP4/VP2 capsid protein phylogeny suggest that age-specific variations in infectivity among subtypes may may be possible. Conclusion: This study adds to the growing body of epidemiological evidence concerning RV. Improving surveillance and testing for RV, including routine whole genome sequencing, may improve understanding of the varied disease outcomes of RV species and subtypes. Future studies could aim to identify specific genetic markers associated with age-specific infectivity of RV, which could inform treatment practices and public health surveillance of RV.
AB - Objectives: Rhinoviruses (RV) represent the most common aetiological agent of all acute respiratory tract infections across all age groups and a significant burden of disease among children. Recent studies have shown that RV-A and RV-C species are associated with increased disease severity. In order to better understand the potential associations between RV species and clinical features among paediatric cases, this study aimed to integrate genetic and epidemiological data using Bayesian phylogenetic methods. Methods: Potential associations between RV species and subtypes, and clinical disease severity using a matched dataset of 52 RV isolates sampled from children (< 18 years) in Sydney, Australia, between 2006 and 2009 were uncovered using epidemiological and phylogenetic methods. Results: It was found that RV-C was significantly more likely to be isolated from paediatric cases aged < 2 years compared with RV-A, although no significant differences in recorded symptoms were observed. Significant phylogenetic-trait associations between age and the VP4/VP2 capsid protein phylogeny suggest that age-specific variations in infectivity among subtypes may may be possible. Conclusion: This study adds to the growing body of epidemiological evidence concerning RV. Improving surveillance and testing for RV, including routine whole genome sequencing, may improve understanding of the varied disease outcomes of RV species and subtypes. Future studies could aim to identify specific genetic markers associated with age-specific infectivity of RV, which could inform treatment practices and public health surveillance of RV.
KW - Epidemiology
KW - Paediatric infections
KW - Phylogenetics
KW - Rhinoviruses
UR - http://www.scopus.com/inward/record.url?scp=85111897675&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85111897675&partnerID=8YFLogxK
U2 - 10.1016/j.ijid.2021.06.046
DO - 10.1016/j.ijid.2021.06.046
M3 - Article
C2 - 34174431
AN - SCOPUS:85111897675
SN - 1201-9712
VL - 110
SP - 69
EP - 74
JO - International Journal of Infectious Diseases
JF - International Journal of Infectious Diseases
ER -